Health Care [ 4/12 ] | Biotechnology [ 13/75 ]
NASDAQ | Common Stock
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.
The company is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 25 | -0.03 Increased by +99.77% | - |
| Aug 14, 25 | -1.58 Increased by +82.92% | - |
| May 15, 25 | -8.46 Decreased by -400.59% | - |
| Mar 31, 25 | -1.07 Increased by +98.03% | -1.31 Increased by +18.32% |
| Nov 13, 24 | -13.25 Decreased by -474.49% | -7.25 Decreased by -82.76% |
| Aug 28, 24 | -9.25 Increased by +69.23% | -19.25 Increased by +51.95% |
| May 15, 24 | -1.69 Increased by +89.81% | -1.44 Decreased by -17.36% |
| Dec 31, 23 | -54.25 Decreased by -2.57 K% | -27.75 Decreased by -95.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by -100.00% | -922.72 K Increased by +58.45% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by -100.00% | 5.43 M Increased by +920.64% | Increased by +N/A% Increased by +N/A% |
| Mar 31, 25 | 0.00 Decreased by -100.00% | -2.26 M Decreased by -4.50% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 725.40 K Increased by +299.15% | -9.27 M Decreased by -3.01 K% | Decreased by -1.28 K% Decreased by -1.36 K% |
| Sep 30, 24 | 1.58 M Decreased by -5.87% | -2.22 M Increased by +51.19% | Decreased by -140.87% Increased by +48.15% |
| Jun 30, 24 | 1.42 M Decreased by -28.71% | -662.03 K Increased by +74.00% | Decreased by -46.57% Increased by +63.53% |
| Mar 31, 24 | 1.39 M Decreased by -44.84% | -2.16 M Decreased by -56.15% | Decreased by -155.72% Decreased by -183.11% |
| Dec 31, 23 | -364.25 K Decreased by -145.64% | 318.15 K Increased by +107.54% | Decreased by -87.34% Increased by +83.49% |